Literature DB >> 25135254

NLRP3 and ASC suppress lupus-like autoimmunity by driving the immunosuppressive effects of TGF-β receptor signalling.

Maciej Lech1, Georg Lorenz1, Onkar P Kulkarni1, Marian O O Grosser1, Nora Stigrot1, Murthy N Darisipudi1, Roman Günthner1, Maximilian W M Wintergerst1, David Anz1, Heni Eka Susanti1, Hans-Joachim Anders1.   

Abstract

OBJECTIVES: The NLRP3/ASC inflammasome drives host defence and autoinflammatory disorders by activating caspase-1 to trigger the secretion of mature interleukin (IL)-1β/IL-18, but its potential role in autoimmunity is speculative.
METHODS: We generated and phenotyped Nlrp3-deficient, Asc-deficient, Il-1r-deficient and Il-18-deficient C57BL/6-lpr/lpr mice, the latter being a mild model of spontaneous lupus-like autoimmunity.
RESULTS: While lack of IL-1R or IL-18 did not affect the C57BL/6-lpr/lpr phenotype, lack of NLRP3 or ASC triggered massive lymphoproliferation, lung T cell infiltrates and severe proliferative lupus nephritis within 6 months, which were all absent in age-matched C57BL/6-lpr/lpr controls. Lack of NLRP3 or ASC increased dendritic cell and macrophage activation, the expression of numerous proinflammatory mediators, lymphocyte necrosis and the expansion of most T cell and B cell subsets. In contrast, plasma cells and autoantibody production were hardly affected. This unexpected immunosuppressive effect of NLRP3 and ASC may relate to their known role in SMAD2/3 phosphorylation during tumour growth factor (TGF)-β receptor signalling, for example, Nlrp3-deficiency and Asc-deficiency significantly suppressed the expression of numerous TGF-β target genes in C57BL/6-lpr/lpr mice and partially recapitulated the known autoimmune phenotype of Tgf-β1-deficient mice.
CONCLUSIONS: These data identify a novel non-canonical immunoregulatory function of NLRP3 and ASC in autoimmunity. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Inflammation; Lupus Nephritis; Systemic Lupus Erythematosus

Mesh:

Substances:

Year:  2014        PMID: 25135254     DOI: 10.1136/annrheumdis-2014-205496

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  37 in total

1.  Glomerular disease: limiting autoimmune tissue injury: ROS and the inflammasome.

Authors:  Santhosh V R Kumar; Hans-Joachim Anders
Journal:  Nat Rev Nephrol       Date:  2014-08-26       Impact factor: 28.314

2.  Advances in Disease Mechanisms and Translational Technologies: Clinicopathologic Significance of Inflammasome Activation in Autoimmune Diseases.

Authors:  J Michelle Kahlenberg; Insoo Kang
Journal:  Arthritis Rheumatol       Date:  2020-01-15       Impact factor: 10.995

3.  Macrophage Uptake of Necrotic Cell DNA Activates the AIM2 Inflammasome to Regulate a Proinflammatory Phenotype in CKD.

Authors:  Takanori Komada; Hyunjae Chung; Arthur Lau; Jaye M Platnich; Paul L Beck; Hallgrimur Benediktsson; Henry J Duff; Craig N Jenne; Daniel A Muruve
Journal:  J Am Soc Nephrol       Date:  2018-02-09       Impact factor: 10.121

Review 4.  Inflammasomes in the pathophysiology of autoinflammatory syndromes.

Authors:  Sarang Tartey; Thirumala-Devi Kanneganti
Journal:  J Leukoc Biol       Date:  2019-10-14       Impact factor: 4.962

Review 5.  Perception of self: distinguishing autoimmunity from autoinflammation.

Authors:  Tessa S van Kempen; Mark H Wenink; Emmerik F A Leijten; Timothy R D J Radstake; Marianne Boes
Journal:  Nat Rev Rheumatol       Date:  2015-05-12       Impact factor: 20.543

6.  NLRP3 negatively regulates Treg differentiation through Kpna2-mediated nuclear translocation.

Authors:  Su-Ho Park; Sunyoung Ham; Arim Lee; Andreas Möller; Tae Sung Kim
Journal:  J Biol Chem       Date:  2019-10-09       Impact factor: 5.157

7.  Macrophage Migration Inhibitory Factor Regulates U1 Small Nuclear RNP Immune Complex-Mediated Activation of the NLRP3 Inflammasome.

Authors:  Min Sun Shin; Youna Kang; Elizabeth R Wahl; Hong-Jai Park; Rossitza Lazova; Lin Leng; Mark Mamula; Smita Krishnaswamy; Richard Bucala; Insoo Kang
Journal:  Arthritis Rheumatol       Date:  2018-12-04       Impact factor: 10.995

Review 8.  Protecting the kidney in systemic lupus erythematosus: from diagnosis to therapy.

Authors:  Naomi I Maria; Anne Davidson
Journal:  Nat Rev Rheumatol       Date:  2020-03-19       Impact factor: 20.543

Review 9.  Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease.

Authors:  Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2016-08-11       Impact factor: 10.121

Review 10.  What is damaging the kidney in lupus nephritis?

Authors:  Anne Davidson
Journal:  Nat Rev Rheumatol       Date:  2015-11-19       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.